H-group (homology)
5054.1 Voltage-gated ion channels
Ligands and drugs
11,470
Member domains
5,240
with ligand contacts (≤ 4 Å)
45.7% of members
2,915
with DrugDomain annotations
25.4% of members
1,207
with a DrugBank compound
10.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5054.1 belongs to X-group 5054 Voltage-gated ion channels, which binds 10.4 ligand superclasses per 20 proteins, broader than 97% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 150 |
| DB04540 | CLR | Cholesterol | 116 |
| DB00142 | GLU | Glutamic acid | 93 |
| DB00171 | ATP | ATP | 84 |
| DB03796 | PLM | Palmitic Acid | 80 |
| DB12393 | ZK1 | Fanapanel | 69 |
| DB03690 | PCW | (Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide | 65 |
| DB00606 | CYZ | Cyclothiazide | 64 |
| DB00145 | GLY | Glycine | 50 |
| DB00201 | CFF | Caffeine | 44 |
| DB09114 | PCF | Colfosceril palmitate | 40 |
| DB03143 | F09 | Nonan-1-Ol | 35 |
| DB02306 | CPL | Palmitoyl-Linoleoyl Phosphatidylcholine | 32 |
| DB06515 | 6EU | Resiniferatoxin | 32 |
| DB03566 | SPD | Spermidine | 28 |
| DB09061 | P0T | Cannabidiol | 28 |
| DB00144 | P5S | Phosphatidyl serine | 24 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 24 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 24 |
| DB08883 | 6ZP | Perampanel | 24 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| Kmetal | POTASSIUM ION | 1,405 |
| CAmetal | CALCIUM ION | 863 |
| POV | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate | 681 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 531 |
| NAmetal | SODIUM ION | 462 |
| CLR | CHOLESTEROL | 399 |
| ZNmetal | ZINC ION | 338 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 257 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 215 |
| PCW | 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 189 |
| GLU | GLUTAMIC ACID | 160 |
| 6OU | [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate | 159 |
| PIO | [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate | 144 |
| PX4 | 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 134 |
| CFF | CAFFEINE | 111 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 110 |
| 9Z9 | (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en | 110 |
| 6EU | resiniferatoxin | 107 |
| PLM | PALMITIC ACID | 107 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 97 |